Increase when all of these conditions are true: your GI symptoms at the current dose have resolved or become minimal, you are not experiencing persistent nausea or vomiting, you feel comfortable with the current level of appetite suppression, and your provider has approved the increase
Appetite is regulated, not just resisted
Trends Cardiovasc Med 9 : 4954
Clinical trials generally identify the most dangerous side effects of drugs, but they can fail to find what symptoms patients are most concerned about, says Lyle H
with insulin and GLP-1 and GIP analogues) has been associated with temporary worsening of diabetic retinopathy (disease of the retina secondary to diabetes)[19]
But on Monday of this week, Novo Nordisk finally announced that they would no longer partner with Hims & Hers a partnership that lasted about two months because the telehealth company is continuing to provide compounded GLP-1s, even after the FDA lifted the shortage declaration